Abstract
IntroductionThe heterogeneity of idiopathic pulmonary fibrosis (IPF) in terms of disease course and treatment response leads to challenges for patients and clinicians in terms of optimal timing for transplantation and/or...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
